Dermatitis
Amgen and Kyowa Kirin Provide Top-Line Results From Rocatinlimab Phase 3 IGNITE Study in Atopic Dermatitits
Amgen
PR-03-25-NI-03Mar 10, 2025
Licensing Agreement
MEI Pharma and Kyowa Hakko Kirin Announce License Agreement to Develop and Commercialize ME-401 in Japan
MEI Pharma, Inc.
PR-M11-18-NI-026Nov 08, 2018
FDA Approval
Kyowa Kirin Announces FDA Approval of Poteligeo® (mogamulizumab-kpkc) for the Treatment of Mycosis Fungoides and Sézary Syndrome
Kyowa Kirin
PR-M08-18-NI-109Aug 29, 2018